Date | Insider | Price | Amount |
---|---|---|---|
9-15-2023 Insider Buy |
Paul Sykes Chief Financial Officer |
$0.16 CAGR » |
$4,605.26 28,607 shares |
5-31-2023 Insider Buy |
Paul Sykes Chief Financial Officer |
$0.30 CAGR » |
$49,999.95 164,636 shares |
5-31-2023 Insider Buy |
Jonathan Trauben |
$0.30 CAGR » |
$28,886.48 97,318 shares |
6-14-2022 Insider Buy |
TCAC Sponsor, LLC >10% Owner |
$10.00 CAGR » |
$6,000,000.00 600,000 shares |
Also See: Institutional Holders of SBIG
Also See: SEC filings
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 09/18/2023 | |
End date: | 05/02/2024 | |
Start price/share: | $0.14 | |
End price/share: | $0.15 | |
Dividends collected/share: | $0.00 | |
Total return: | 7.14% | |
Annualized Gain: | 11.49% | |
Starting investment: | $10,000.00 | |
Ending investment: | $10,714.00 | |
Years: | 0.62 |
SpringBig Holdings Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent SpringBig Holdings insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding SBIG
Free SBIG Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Other companies seeing insider buying close in time to when the SpringBig Holdings Insider Buying occurred are:
Merck and Insider Buying |